{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T09:37:00Z","timestamp":1791625020945,"version":"4.3.4"},"reference-count":18,"publisher":"ALUNA","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Wiad Lek"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:p>Aim: To carry out a comprehensive evaluation of treatment modification for patients with seasonal allergic rhinitis (SAR) complicated by anxiety-neurotic disorders.\nMaterials and Methods: Patients with SAR in the acute stage on the background of anxiety disorders were studied. Immunological studies were carried out, an assessment of the dynamics of indicators of the quality of life of patients, the level of anxiety \/ depression was assessed. In the clinical group, a variant of therapy modification was proposed.\nResults: Significant changes in the subpopulation ratio of lymphocytes, an increase in the immunoregulatory index, which indicated the severity of the immunological process, were revealed in SAR patients in the acute stage against the background of anxiety disorders. At the same time, a significant activation of the humoral link of immunity was observed: an increase and a significant increase in IgE in the blood serum and an increase in the content of sIgA in the nasal secretion. In most patients, eosinophilia was found in the peripheral blood and in the rhinocytogram before treatment. In the study of the quality of life of patients, changes in many parameters were found.\nConclusions: The combination of \u201cNazafort Allergy Protection\u201d and Atarax seems to be the most successful, which significantly improved the physical and psycho-emotional state of patients with SAR, complicated by anxiety and neurotic disorders. This combination led to an increase in the stress resistance of patients.<\/jats:p>","DOI":"10.36740\/wlek202401109","type":"journal-article","created":{"date-parts":[[2024,3,3]],"date-time":"2024-03-03T17:03:20Z","timestamp":1709485400000},"page":"62-67","source":"Crossref","is-referenced-by-count":4,"title":["Evaluation of the treatment strategy for complicated allergic rhinitis"],"prefix":"10.36740","volume":"77","author":[{"given":"Lilia","family":"Buria","sequence":"first","affiliation":[{"name":"POLTAVA STATE MEDICAL UNIVERSITY, POLTAVA, UKRAINE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nataliia","family":"Moisieieva","sequence":"additional","affiliation":[{"name":"POLTAVA STATE MEDICAL UNIVERSITY, POLTAVA, UKRAINE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kapustianska","sequence":"additional","affiliation":[{"name":"POLTAVA STATE MEDICAL UNIVERSITY, POLTAVA, UKRAINE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrii","family":"Vakhnenko","sequence":"additional","affiliation":[{"name":"POLTAVA STATE MEDICAL UNIVERSITY, POLTAVA, UKRAINE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iryna","family":"Zviagolska","sequence":"additional","affiliation":[{"name":"POLTAVA STATE MEDICAL UNIVERSITY, POLTAVA, UKRAINE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olena","family":"Vlasova","sequence":"additional","affiliation":[{"name":"POLTAVA STATE MEDICAL UNIVERSITY, POLTAVA, UKRAINE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariia","family":"Rumiantseva","sequence":"additional","affiliation":[{"name":"POLTAVA STATE MEDICAL UNIVERSITY, POLTAVA, UKRAINE"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"22436","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref0","unstructured":"1. Knight J, Nigam Y. The lymphatic system 4: allergies, anaphylaxis and anaphylactic shock. Nursing Times. 2021; 117(1): 54\u201358."},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"2. Fokkens WJ, Lund VJ, Hopkins C et al. European Position Paper on Rhinosinusitis and Nasal Polyps. Rhinology. 2020;58 (29): 1\u2013464. doi: 10.4193\/Rhin20.600. DOI","DOI":"10.4193\/Rhin20.600"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Emeryk A, Maksymiuk J, Janeszek K. New guidelines for the treatment of seasonal allergic rhinitis. Postepy Dermatol Alergol. 2019; 36(3): 255\u2013260. doi: 10.5114\/ada.2018.75749. DOI","DOI":"10.5114\/ada.2018.75749"},{"key":"ref3","unstructured":"4. Chistik T. Suchasni mozhlyvosti antyhistaminnoyi terapiyi alerhichnoho rynitu ta kropyv\"yanky [Modern possibilities in the treatment of allergic rhinoconjunctivitis and urticaria: focus on bilastine (NixarR)]. News of Medicine and Pharmacy. 2016;5(574): 3\u20134. (in Ukrainian)."},{"key":"ref4","unstructured":"5. Bro\u017cek JL, Bousquet J, Agache I et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision. J. Allergy Clin. Immunol. 2017;140(4): 950\u2013958."},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Zuberbier T, Aberer W, Asero R et al. The EAACI\/GA2LEN\/EDF\/WAO guideline for the definition, classification, diagnosis and management of urticaria. Allergy. 2018; 73(7): 1393 \u20131414. doi: 10.1111\/all.13397. DOI","DOI":"10.5114\/pja.2020.93828"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Shabanov DV, Lutkovskaya JuE. Actual Antihistamine Therapy. Medical Council. 2020; 16: 26\u201335. doi: 10.21518\/2079\u2013701X-2020\u201316\u201326\u201335. DOI","DOI":"10.21518\/2079-701x-2020-16-26-35"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Wang XY, Lim-Jurado M, Prepageran N \u0435t al. Treatment of allergic rhinitis and urticaria: a review of the newest antihistamine drug bilastine. Ther. Clin. Risk. Manag. 2016;12: 585\u2013597. doi:10.2147\/TCRM.S105189. DOI","DOI":"10.2147\/tcrm.s105189"},{"key":"ref8","unstructured":"9. Vermetten E, Frankova I, Carmi L et al. Risk management of terrorism induced stress: NATO Science for Peace and Security Series, Subseries E: Human and Societal Dynamics. IOS Press. The Netherlands. 2020. https:\/\/www.nato.int\/cps\/en\/natohq\/topics_181867.htm? [date access 08.04.2023]"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Morina N, Hoppen TH, Priebe S. Out of sight, out of mind: refugees are just the tip of the iceberg. An illustration using the cases of depression and posttraumatic stress disorder. Frontiers in Psychiatry. 2020;11: 179. doi: 10.3389\/fpsyt.2020.00179. DOI","DOI":"10.3389\/fpsyt.2020.00179"},{"key":"ref10","unstructured":"11. Moisieieva NV, Burya LV, Kapustianskaya AA et al. Comprehensive patterns of comorbidity: copd and depression. Aspects of treatment. Wiadomo\u015bci Lekarskie. 2018;71(3): 395-399."},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Khorram-Manesh A, Burkle FM, Goniewicz K, Robinson Y. Estimating the Number of Civilian Casualties in Modern Armed Conflicts \u2013 A Systematic Review. Frontiers in public health. 2021. doi:10.3389\/fpubh.2021.765261. DOI","DOI":"10.3389\/fpubh.2021.765261"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Mahmood HN, Ibrahim H, Goessmann K et al. Post-traumatic stress disorder and depression among Syrian refugees residing in the Kurdistan region of Iraq. Conflict Health. 2019; 13: 1. doi: 10.1186\/s13031-019-0238-5. DOI","DOI":"10.1186\/s13031-019-0238-5"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Dro\u017e\u0111ek B, Rodenburg J, Moyene-Jansen A. \u226aHidden\u226b and diverse long-term impacts of exposure to war and violence. Frontiers in Psychiatry. 2020; 10: 975. doi:10.3389\/fpsyt.2019.00975. DOI","DOI":"10.3389\/fpsyt.2019.00975"},{"key":"ref14","unstructured":"15. Kravchun PG, Babazhan VD, Lomakina OV et al. Allergic rhinitis. Specific immunodiagnostics and immunotherapy: method. order for students and intern doctors. Kharkiv: KhSMU, 2013, p.20."},{"key":"ref15","unstructured":"16. Kuznetsova LV, Babadzhan VD, Kharchenko NV. Imunolohiia: pidruchnyk. [Immunology: textbook]. Vinnytsia: Mercury-Podillia. 2013, p.565. (in Ukrainian)"},{"key":"ref16","unstructured":"17. Babazhan VD, Yermak OS, Amer LB et al. Kharchova alerhiya, alerhen komponenty, suchasni terapevtychni pidkhody. [Food allergy, allergen components, modern therapeutic approaches kharchova alerhiya, alerhen komponenty, suchasni terapevtychni pidkhody]. Suchasni problemy farmakoterapiyi i pryznachennya likars'kykh zasobiv. Materialy III Mizhnarodnoyi naukovo-praktychnoyi konferentsiyi. 2019, pp.37-40."},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. Mikkelsen RL, Middelboe T, Pisinger Ch, Stage KB. Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). A review. Nord J Psychiatry. 2004;58(1):65-70. doi: 10.1080\/08039480310000824.","DOI":"10.1080\/08039480310000824"}],"container-title":["Wiadomo\u015bci Lekarskie"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,3,3]],"date-time":"2024-03-03T17:03:27Z","timestamp":1709485407000},"score":1,"resource":{"primary":{"URL":"https:\/\/wiadlek.pl\/wp-content\/uploads\/archive\/2024\/WiadLek2024i1.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024]]},"published-print":{"date-parts":[[2024,1]]}},"URL":"https:\/\/doi.org\/10.36740\/wlek202401109","archive":["Internet Archive"],"relation":{},"ISSN":["0043-5147"],"issn-type":[{"value":"0043-5147","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]}}}